PATENT CLAIM ANALYSIS

Application Number: 16224902
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-08
Patent Classification: ["514", "256000"]

Abstract:
The invention provides a salt of a tetrahydropyranylmethylaminopyrimidine amide, such as the citrate salt of (4-((3R,4R)-3-methoxytetrahydropyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone, pharmaceutical compositions containing the same, processes for preparing the same, and methods of medical treatment using the same.

Claim (Index 38):
A tablet or capsule, comprising a pharmaceutical composition according to  claim 11 .

Metadata:
- Claim Count in Document: 64.0
- Percentile: 98.0
- Lexical Diversity: 1.65
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15849929', '14442860', '15312440', '14118377', '11032990']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8039459096224929
- 35 USC 102 Novelty (BERT): 0.6297888942290021
- Combined Prediction Score: 0.7865302080831438
- Mean Citation Score: 436.8918299999999
- Max Citation Score: 831.6977
- Similarity Product: 519.7911341355205

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test